Ivermectin as a bird anthelmintic--trials with naturally infected domestic fowl.
To evaluate the use of ivermectin as a bird anthelmintic, 29 White Leghorn hens naturally infected with Ascaridia spp., Heterakis spp. and Capillaria spp. were treated with 0.2, 2 or 6 mg/kg intramuscularly or 0.2 or 0.8 mg/kg orally. Faecal samples were collected before treatment and at autopsy, 2, 6, or 16 days after treatment, when the intestines were also examined for helminths. None of the treatments gave satisfactory anthelmintic results.
Anthelmintic efficacy of ivermectin against Syngamus trachea and Capillaria spp. in pheasant.
Ivermectin (IVM) was perorally administered in dosage schemes 1 x 0.8 mg/kg of body weight (b.w.), 1 x 1.6 mg/kg h.w., 3 x 0.8 mg/kg b.w., and 3 x 1.6 mg/kg b.w. to pheasants infected by Syngamus trachea and Capillaria spp. The samples of faeces were coprologically examined. The clinical state of pheasant was controlled. In all of the used therapeutical schemes the helminthostatic or partially helminthocide effect against adults of worms was reached. The clinical signs of helmithoses were reduced only. IVM in tested doses is not possible to recommend as an effective drug of pheasant syngamosis and capillariosis.